Scientists have developed an artificial intelligence-powered method for detecting tumor DNA in blood, demonstrating unprecedented sensitivity in predicting cancer recurrence. This AI tool, as reported by Inside_PM, has also been used to better predict whether patients will respond to immune checkpoint inhibitors. The research, involving Dr. Dan Landau and teams from Weill Cornell, NY Genome Center, and MSK Cancer Center, has been published in Nature Medicine. Additionally, a new ultrasensitive liquid biopsy technology has been reported to spot cancer earlier than standard methods. The MRD-EDGE leverages advanced machine learning (ML) for whole-genome sequencing (WGS) and circulating tumor DNA (ctDNA) detection across clinical contexts.
AI-Powered Liquid Biopsy Delivers Ultrasensitive Cancer Detection An AI-powered test shows unprecedented sensitivity in predicting cancer recurrence from blood samples. Learn more: https://t.co/ElkXdfTGlx https://t.co/TbpAZBqkV7
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, says a team led by Dr. Dan Landau (@landau_lab) and researchers at @nygenome and @MSKCancerCenter. https://t.co/2ZCZMnsnBG https://t.co/SpOjv0Uui6
"Did you know that you don't need targeted panels for ultra-sensitive MRD?" 🥳 Down right ebullient to share our latest 🥳@NatureMedicine ! MRD-EDGE leverages advanced #ML for #WGS #ctDNA detection across clinical context https://t.co/drJasWVwoE #DeepLearning 🪡 https://t.co/mmMIDNQNbE
Ultrasensitive liquid biopsy tech spots #cancer earlier than standard methods @WeillCornell @NatureMedicine https://t.co/m2qPiodfwG
Yet another use of AI in the lab. According to @Inside_PM, scientists have used an AI tool to better predict whether patients will respond to immune checkpoint inhibitors. Find out why it's important ⬇️ https://t.co/qKNB9rTds7 #Labai #eln #lifesciences #lims #immuneai